Skip to main content
. 2016 Mar 2;48(5):1868–1876. doi: 10.3892/ijo.2016.3413

Figure 2.

Figure 2

Corilagin suppresses the proliferation of cholangiocarcinoma (CCA) cell lines. Evaluation of the cell proliferation curve by MTT assays. The CCA cell lines QBC939 (A) and MZ-Cha-1 (B) were treated with 30 μmol/l corilagin for the indicated times. The data were obtained from three experiments and represent means ± SD. *P<0.01 versus control cells.